Wednesday, August 31, 2022 8:05:47 PM
Right now, this company (like most pinks) is not capable of trading on fundamentals. It has some good baseline stuff (no recent history of dilution, stable share structure, repeated claims by management that no R/S is in the works), but the hype cycle that typically drives pinks to the next level has run dry - they've made too many promises, and have failed to show (via quarterly/annual reports) that any have come to fruition. They need to demonstrate that they can deliver before PPS will make a meaningful move.
This isn't womp-womp, this is facts. We've all seen the diminishing impacts of the Company's PRs over the past 18 months...Until there is something resembling concrete results (reported in the fins), most folks are going to continue to stand by and wait on the sideline.
Recent SHMN News
- Shares of this BioPharma on a Tear as it Successfully Engineered a T-Cell From a Healthy Human Donor • AllPennyStocks.com • 06/10/2024 06:30:00 PM
- Gene Editing Company Joins Forces to Advance Gene Therapy • AllPennyStocks.com • 04/01/2024 03:46:00 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM